Interleukin-6 Gene Promoter Region Polymorphism in Patients with Dilated Cardiomyopathy: A Prospective Observational Study
Indian Journal of Pharmaceutical and Biological Research · 28.04.2026 · 14 (02) · 59-62
DOI: 10.30750/ijpbr.14.2.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical and Biological Research, online erschienen am 28.04.2026. Verfasst von Shiv Purari und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Dilated cardiomyopathy (DCM) is characterized by enlargement of the ventricular chambers with reduced myocardial contractility, leading to impaired cardiac performance. Its pathogenesis is multifactorial, involving a complex interplay between genetic susceptibility and inflammatory mechanisms. Interleukin-6 (IL-6), a pro-inflammatory cytokine, plays a key role in myocardial remodeling, and polymorphisms in its promoter region may influence disease susceptibility and severity.
Objective
To examine the relationship between IL-6 promoter gene polymorphism and clinical outcomes among patients with DCM.
Methods
This study was conducted at a tertiary care center inPawapuri, over 10 months (April 2025–January 2026). A total of 110 patients diagnosed with DCM were included. IL-6 promoter polymorphism (−174 G/C) was analyzed using PCR-based techniques. Clinical parameters and outcomes were recorded and statistically analyzed.
Results
The GG genotype was most prevalent (52.7%), followed by GC (34.5%) and CC (12.8%). Patients with the CC genotype showed significantly reduced left ventricular ejection fraction (LVEF) and higher NYHA class. The CC genotype was associated with increased hospitalization and mortality.
Conclusion
IL-6 promoter polymorphism is significantly associated with disease severity and outcomes in DCM patients, suggesting its potential role as a prognostic biomarker.
Zitieren
APA
Purari, S., Kumar, D., Kumar, S., & Kumar, S. (2026). Interleukin-6 Gene Promoter Region Polymorphism in Patients with Dilated Cardiomyopathy: A Prospective Observational Study. Indian Journal of Pharmaceutical and Biological Research, 14(02), 59-62. https://doi.org/10.30750/ijpbr.14.2.12
Vancouver
Purari S, Kumar D, Kumar S, Kumar S. Interleukin-6 Gene Promoter Region Polymorphism in Patients with Dilated Cardiomyopathy: A Prospective Observational Study. Indian Journal of Pharmaceutical and Biological Research. 2026;14(02):59-62. doi:10.30750/ijpbr.14.2.12
BibTeX
@article{Purari2026,
author = {Purari, Shiv and Kumar, Dhirendra and Kumar, Sanjay and Kumar, Sujit},
title = {Interleukin-6 Gene Promoter Region Polymorphism in Patients with Dilated Cardiomyopathy: A Prospective Observational Study},
journal = {Indian Journal of Pharmaceutical and Biological Research},
year = {2026},
volume = {14},
number = {02},
pages = {59--62},
doi = {10.30750/ijpbr.14.2.12}
}
EUVIMED